EUVIMEDEUVIMED entdecken
Crossref

DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks

Ayman Uzayr, Mustafa Meraj, Motassim Khan, . R. Prathyusha

INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT · 13.04.2026 · 10 (04) · 1-9

DOI: 10.55041/ijsrem58550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT, online erschienen am 13.04.2026. Verfasst von Ayman Uzayr und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abstract—DrugInsight is an end-to-end, interpretable drug- drug interaction (DDI) prediction system. It evaluates interaction probability and severity while generating structured clinical explanations. The system utilizes RDKit and PyTorch Geometric to process drug SMILES strings into molecular graphs. These graphs are encoded by an AttentiveFP Graph Neural Network (GNN) into fixed-length structural embeddings. The embed- dings are concatenated with a comprehensive 12-dimensional pharmacological feature vector. This vector encompasses shared biological entities from DrugBank and post-market safety signals (PRR) from the TWOSIDES database. A Multi-Layer Perceptron (MLP) binary classifier processes this combined representation. The final interaction probability is computed using a tiered fusion model. This model adaptively weights curated DrugBank rules, ML classifier scores, and TWOSIDES pharmacovigilance signals to generate a unified risk index and severity classification. The system achieves a validation AUC of 0.7065 under a rigorous cold-start drug-level split. This demonstrates robust generaliza- tion to entirely unseen compounds. DrugInsight ensures high transparency through a rule-based explainer detailing metabolic competition, pharmacodynamic overlap, and explicit clinical rec- ommendations. The system is packaged for versatile deployment via a Streamlit web interface, a FastAPI REST endpoint, and a command-line interface (CLI). Index Terms—Drug-drug interactions, graph neural networks, AttentiveFP, evidence fusion, explainability, pharmacovigilance, DrugBank, TWOSIDES

Zitieren

APA

Uzayr, A., Meraj, M., Khan, M., & Prathyusha, R. (2026). DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT, 10(04), 1-9. https://doi.org/10.55041/ijsrem58550

Vancouver

Uzayr A, Meraj M, Khan M, Prathyusha R. DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT. 2026;10(04):1-9. doi:10.55041/ijsrem58550

BibTeX
@article{Uzayr2026,
  author = {Uzayr, Ayman and Meraj, Mustafa and Khan, Motassim and Prathyusha, . R.},
  title = {DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks},
  journal = {INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT},
  year = {2026},
  volume = {10},
  number = {04},
  pages = {1--9},
  doi = {10.55041/ijsrem58550}
}
Kostenlos starten →